ID: ALA3091618

Max Phase: Preclinical

Molecular Formula: C22H19NO5

Molecular Weight: 377.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(CC(c2ccccc2)c2ccccc2)c(C(=O)O)c(C(=O)O)c1O

Standard InChI:  InChI=1S/C22H19NO5/c1-13-20(24)19(22(27)28)18(21(25)26)17(23-13)12-16(14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,16,24H,12H2,1H3,(H,25,26)(H,27,28)

Standard InChI Key:  XGKYULQERWQZOR-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.40Molecular Weight (Monoisotopic): 377.1263AlogP: 3.87#Rotatable Bonds: 6
Polar Surface Area: 107.72Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.73CX Basic pKa: 2.45CX LogP: 3.98CX LogD: -1.36
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: -0.01

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source